{"title":"Peristomal Hidradenitis Suppurativa: A Case and Review of the Literature","authors":"Daniel Sosh, V. Varra, J. Kaffenberger","doi":"10.18061/ad.v1i1.8816","DOIUrl":null,"url":null,"abstract":"Hidradenitis suppurativa (HS) is a chronic, inflammatory condition of apocrine gland-bearing skin that typically presents as deep, inflamed lesions in the axillary, inguinal, perineal, and mammary regions. We present a rare case of a man in his 60s with a history of HS who presented with a peristomal sinus tract, as well as non-healing, draining wounds around his stoma site that responded well to adalimumab therapy. A compounded clobetasol ointment with poly(ethelyene oxide) polymers (POLYOXTM, Dupoont) was utilized to maintain stoma appliance adhesion, and his lesions effectively cleared with adalimumab.","PeriodicalId":376900,"journal":{"name":"Academic Dermatology","volume":"21 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Academic Dermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18061/ad.v1i1.8816","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Hidradenitis suppurativa (HS) is a chronic, inflammatory condition of apocrine gland-bearing skin that typically presents as deep, inflamed lesions in the axillary, inguinal, perineal, and mammary regions. We present a rare case of a man in his 60s with a history of HS who presented with a peristomal sinus tract, as well as non-healing, draining wounds around his stoma site that responded well to adalimumab therapy. A compounded clobetasol ointment with poly(ethelyene oxide) polymers (POLYOXTM, Dupoont) was utilized to maintain stoma appliance adhesion, and his lesions effectively cleared with adalimumab.